Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
IDNAISharesINDEX

iShares Genomics Immunology and Healthcare ETF

$39.25-2.12% vs prior close
264452-WK

Price through Nov 16, 2026 · Flows through Nov 13, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.

The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.

IDNA price

Source: Market tape, daily closes; price return, distributions not reinvested
Table
DateIDNA close
Oct 16, 2026$40.54
Oct 19, 2026$40.96
Oct 20, 2026$42.58
Oct 21, 2026$42.70
Oct 22, 2026$41.04
Oct 23, 2026$40.91
Oct 26, 2026$40.95
Oct 27, 2026$42.00
Oct 28, 2026$43.47
Oct 29, 2026$42.99
Oct 30, 2026$42.76
Nov 2, 2026$41.70
Nov 3, 2026$42.47
Nov 4, 2026$44.15
Nov 5, 2026$41.42
Nov 6, 2026$42.31
Nov 9, 2026$43.57
Nov 10, 2026$42.53
Nov 11, 2026$42.22
Nov 12, 2026$40.86
Nov 13, 2026$40.10
Nov 16, 2026$39.25

Daily net flows, 1M

Net inflow over the range: +$36M

  • Inflow / above zero
  • Outflow / below zero
Oct 13Oct 15Oct 19Oct 21Oct 23Oct 27Oct 29Nov 2Nov 4Nov 6+$18MNov 10+$4MNov 13Oct 13Oct 16Oct 21Oct 26Oct 29Nov 3Nov 6+$18MNov 11+$4MNov 13Oct 13Oct 21Oct 29Nov 6+$18M+$4MNov 13
Source: Daily creation and redemption records
Show as table
LabelValue ($)
Oct 13$0
Oct 14$0
Oct 15$0
Oct 16$0
Oct 19$0
Oct 20$0
Oct 21$2.1M
Oct 22$6.2M
Oct 23$2M
Oct 26$0
Oct 27$0
Oct 28$0
Oct 29$0
Oct 30$0
Nov 2$0
Nov 3$8.5M
Nov 4$0
Nov 5$2.1M
Nov 6−$7M
Nov 9$18M
Nov 10$0
Nov 11$2M
Nov 12−$2M
Nov 13$4M
The desk’s read

Money keeps arriving — +$36M of net inflows over the past month, about 10.6% of the fund's asset base, while the price has returned +49.9% so far this year. At 0.47% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.

COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH

$340Massets under management
0.47%expense ratio · $47 per $10,000 a year
+$36Mnet flow, trailing month
163Kavg daily volume, 30 days
50holdings · US-domiciled
2019listed June 11, 2019 · beta 1.10
The book at a glance
MRNA-3.6%TWST-5.9%REGN-0.3%EXEL-2.8%VRTX-0.2%MRK-2.2%INCY-0.6%RVMD-3.1%BNTX-0.4%IOVA-2.7%ABCL-3.2%CAI-8.9%IDYA-4.6%IBRX-0.7%RCUS-3.3%VIR-3.8%NVAX-5.5%CRSP-4.4%NUVB-3.8%XNCR-4.6%RIGL-1.6%CRVSVSTMJANX4528.T1.6%45281.5%4502.T4.1%45023.8%

CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS

Holdings
#HoldingWeightPriceDay52-wk
1MRNAMODERNA13.74%$215.27-3.6%
2TWSTTWIST BIOSCIENCE4.71%$105.04-5.9%
3REGNREGENERON PHARMACEUTICALS4.39%$952.40-0.3%
4EXELEXELIXIS3.82%$67.10-2.8%
5VRTXVERTEX PHARMACEUTICALS3.52%$537.79-0.2%
6MRKMERCK & CO3.57%$144.46-2.2%
7INCYINCYTE3.45%$120.27-0.6%
8RVMDREVOLUTION MEDICINES3.37%$166.87-3.1%
9BNTXBIONTECH SE2.84%$85.26-0.4%
10IOVAIOVANCE BIOTHERAPEUTICS2.76%$7.55-2.7%
11ABCLABCELLERA BIOLOGICS2.47%$11.12-3.2%
12CAICaris Life Sciences2.59%$21.00-8.9%
13IDYAIDEAYA BIOSCIENCES2.42%$30.36-4.6%
14IBRXIMMUNITYBIO2.08%$5.98-0.7%
15RCUSARCUS BIOSCIENCES1.34%$16.86-3.3%

The full book, free with one sign-in.

Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.

Sign in to see all 50

Sector weights

  • Health Care99.76%
  • Cash and/or Derivatives0.24%
Source: Portfolio composition, latest disclosure
Show as table
ItemValue (%)
Health Care99.76%
Cash and/or Derivatives0.24%

Country weights

  • United States63.62%
  • Germany7.08%
  • France6.44%
  • Denmark6.09%
  • Japan5.56%
  • Switzerland3.4%
  • United Kingdom2.79%
  • Canada2.46%
Source: Portfolio composition, latest disclosure
Show as table
ItemValue (%)
United States63.62%
Germany7.08%
France6.44%
Denmark6.09%
Japan5.56%
Switzerland3.4%
United Kingdom2.79%
Canada2.46%
Performance
1 week-7.7%
1 month-3.2%
3 months+11.4%
6 months+36.2%
YTD+49.9%
1 year—
3 years—

PRICE RETURN, DISTRIBUTIONS NOT REINVESTED

Net flows
1 week+$4M
1 month+$36M
3 months+$98M
YTD+$134M
1 year+$138M

CREATION/REDEMPTION DOLLARS, DAILY RECORDS

Monthly net flows

  • Inflow / above zero
  • Outflow / below zero
−$5.2MNov+$4MDec$0Jan+$3.1MFeb+$3MMar+$7.7MApr$0May+$18.3MJul+$22.5MAug+$20.2MSep+$33.7MOct+$25.7MNov−$5.2MNov+$4MDec$0Jan+$3.1MFeb+$3MMar+$7.7MApr$0May+$18.3MJul+$22.5MAug+$20.2MSep+$33.7MOct+$25.7MNovNovJanMarMayAug+$33.7M+$25.7MNov
Source: Daily creation/redemption records, trailing twelve months
Show as table
LabelValue ($)
Nov−$5.2M
Dec$4M
Jan$0
Feb$3.1M
Mar$3M
Apr$7.7M
May$0
Jul$18.3M
Aug$22.5M
Sep$20.2M
Oct$33.7M
Nov$25.7M
The risk read
45%realized volatility, 30 days (annualized)
31%realized volatility, 1 year
-11.1%deepest fall from a peak, 1 year
-11.1%latest close versus that peak

The top holding is 13.7% of the book; the top ten carry 52%. Spread across 68+ names, it behaves like roughly 24 equally-weighted positions.

VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK

Options tape
3calls · latest snapshot
3puts · latest snapshot
1.00put/call ratio
239Kshares traded
Most-traded holdings, options premiumBullishBearish
MRNA MODERNA$30M$26M
MRK MERCK & CO$6M$5M
REGN REGENERON PHARMACEUTICALS$4M$2M
TWST TWIST BIOSCIENCE$1M$1M
RVMD REVOLUTION MEDICINES$576,252$1M

TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES

The case against IDNA

Due diligence cuts both ways. These funds sit on the same shelf and beat IDNA on at least one dimension that matters — the fee, the asset base, or where the money is going.

FundFeeAssetsFlow, 1MThe case
SPDW SPDR Portfolio Developed World ex-US ETF0.03%$41.6B+$917M-44bp on fee · 123× the assets · +$917M in over the monthHead-to-head
SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF0.03%$18.4B+$199M-44bp on fee · 54× the assets · +$199M in over the monthHead-to-head
IJH iShares Core S&P Mid-Cap ETF0.05%$123.7B+$109M-42bp on fee · 364× the assets · +$109M in over the monthHead-to-head
IDEV iShares Core MSCI International Developed Markets ETF0.04%$34B+$587M-43bp on fee · 100× the assets · +$587M in over the monthHead-to-head
IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF0.04%$23.7B+$422M-43bp on fee · 70× the assets · +$422M in over the monthHead-to-head
Sign in to save this to The RecordA timestamped copy for the file — documentation, not advice.

Watch & listen: IShares

From the manager behind IDNAAll of Watch & Listen
ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.